NCT03680456View on ClinicalTrials.gov

Postoperative Replacement of Intraoperative Iron Losses

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Blood Loss Anemia
Interventions
DRUG

Ferric carboxymaltose

maximum of 750mg in U.S. is given, maximum of 1000mg in EU

DRUG

Crystalloid

an equivalent volume dose of Natriumchlorid is administered

Trial Locations (1)

Unknown

Universitätsklinik für Anästhesie und Intensivmedizin, Linz

All Listed Sponsors
lead

Kepler University Hospital

OTHER

NCT03680456 - Postoperative Replacement of Intraoperative Iron Losses | Biotech Hunter | Biotech Hunter